Sagentia selected as lead development partner for Chrono Therapeutics’ wearable ‘smart’ smoking cessation device
Sagentia, a global science, product and technology development company, announced today that it is working with Chrono...
Sagentia partners with Premaitha Health to develop first to market non-invasive diagnostic for prenatal screening
Sagentia, a leading global science, technology & product development company, is working with Premaitha Health, a...
Sagentia selected as development partner for SetPoint Medical’s novel neuromodulation device to treat chronic inflammatory disease
Sagentia, a global technology and product development company, has been hired by SetPoint Medical to work on the...
Breakthrough surgical lighting technology launched at Medica
Quaser eLite, a ground-breaking new surgical lighting system incorporating next generation HD LED technology and a...
Lightpoint Medical and Sagentia win £125,000 award in TSB Photonics for Health competition
Lightpoint Medical and Sagentia Product Development announced today that they have jointly received a grant award in...
Sagentia partners with Senseonics to develop novel connected health solution to improve diabetics’ lives
Sagentia, a global technology, and product development company, announced today that it has developed a medically...
Sagentia delivers alpha prototype of new microbial genotyping system for PathoGenetix Inc.
Sagentia Inc., a global technology, and product development company, announced today that it has completed initial...
PathoGenetix and Sagentia to develop commercial scale rapid microbial detection system
PathoGenetix’s proprietary GSS technology combines automated sample preparation and single molecule detection making...
